GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹582 Cr | ₹484 Cr | ₹811 Cr | ₹578 Cr | ₹490 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹582 Cr |
Mar2023 | ₹484 Cr |
Mar2022 | ₹811 Cr |
Mar2021 | ₹578 Cr |
Mar2020 | ₹490 Cr |
How is Cash Flow from Operating Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹582 Cr | 20.20 | |
Mar2023 | ₹484 Cr | -40.27 | |
Mar2022 | ₹811 Cr | 40.29 | |
Mar2021 | ₹578 Cr | 17.82 | |
Mar2020 | ₹490 Cr | - |
Compare Cash Flow from Operating Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹34,946.4 Cr | -3.7% | -9.2% | -5.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,461.0 Cr | 1.4% | -4.1% | 32.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,983.0 Cr | -4.2% | -5.1% | 59.6% | Stock Analytics | |
CIPLA | ₹112,735.0 Cr | -2.2% | -7.3% | 0.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,913.9 Cr | -7.1% | -13.8% | 8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,815.0 Cr | -6.4% | -5.2% | 31.2% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -3.7% |
-9.2% |
-5.9% |
SENSEX | -2.2% |
-4% |
5.5% |
You may also like the below Video Courses